Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 79-86, April 2010

Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy

  • Harald Paganetti

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Massachusetts General Hospital, Francis H Burr Proton Therapy Center, Boston, MA 02114, USA.
  • ,
  • Michael Goitein

      Affiliations

    • Harvard Medical School, Boston, MA, USA
  • ,
  • Katia Parodi

      Affiliations

    • Heidelberg Ion-Beam Therapy Centre, Heidelberg, Germany

Received 11 September 2008; received in revised form 11 March 2009; accepted 14 March 2009. published online 27 April 2009.

Abstract 

Background and purpose

Antiprotons have been suggested as a possibly superior modality for radiotherapy, due to the energy released when they annihilate, which enhances the Bragg peak and introduces a high-LET component to the dose. Previous studies have focused on small-diameter near-monoenergetic antiproton beams. The goal of this work was to study more clinically relevant beams.

Methods

We used Monte Carlo techniques to simulate 120 and 200MeV beams of both antiprotons and protons of 1×1 and 10×10cm2 areas, impinging on water.

Results

An annihilating antiproton loses little energy locally; most goes into long-range secondary particles. When clinically typical field sizes are considered, these particles create a substantial dose halo around the primary field and degrade its lateral fall-off. Spreading the dose in depth further intensifies these effects.

Conclusions

The physical dose distributions of spread-out antiproton beams of clinically relevant size (e.g. 10×10cm2 area) are substantially inferior to those of proton beams, exhibiting a dose halo and broadened penumbra. Studies on the value of antiproton beams, taking radiobiological effectiveness into account, need to assess such realistic beams and determine whether their inferior dose distributions do not undermine the potential value of antiprotons for all but the smallest fields.

Keywords: Antiprotons, Radiation therapy, Monte Carlo

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00141-8

doi:10.1016/j.radonc.2009.03.020

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 79-86, April 2010